DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study
Launched by ALCON RESEARCH · Jun 26, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study includes a Baseline visit and a Year 1 visit.
The Baseline visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a DAILIES TOTAL1 sphere, toric, or multifocal soft contact lens prescription was released. The Baseline visit will be retrospective. All assessments at baseline will be obtained from chart reviews.
The Year 1 visit is defined as the visit that occurs 1 year (-2/+4 months) since the Baseline visit during which period the subject is wearing prescribed lenses and a ...
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • At baseline: 7 years of age or older for sphere and toric wearers, 40 years of age or older for multifocal wearers.
- • Wearers of delefilcon A (sphere, toric, or multifocal) soft contact lenses of the same design in both eyes who have already begun use of the lens type and have purchased at least 3-month supply of lenses at baseline.
- • Best corrected distance visual acuity (BCVA) 20/25 or better in each eye at baseline.
- • Other protocol-defined inclusion criteria may apply.
- Key Exclusion Criteria:
- • Any ocular disease or condition that would contraindicate contact lens wear at baseline.
- • Use of systemic or ocular medications that would contraindicate contact lens wear at baseline.
- • Other protocol-defined exclusion criteria may apply.
About Alcon Research
Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Spokane, Washington, United States
Medina, Minnesota, United States
Memphis, Tennessee, United States
Edina, Minnesota, United States
Saint Louis, Missouri, United States
Eden Prairie, Minnesota, United States
San Diego, California, United States
West Palm Beach, Florida, United States
Fort Worth, Texas, United States
San Diego, California, United States
Ponte Vedra Beach, Florida, United States
New York, New York, United States
Saint George, Utah, United States
Patients applied
Trial Officials
Clinical Trial Lead, Vision Care
Study Director
Alcon Research, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported